Traditional nanoparticle production relies heavily on "top-down" physical methods or "bottom-up" chemical reduction. While effective, these processes frequently utilize hazardous reducing agents, such as sodium borohydride, and harsh organic solvents that leave toxic residues. As noted by Juan Shu et al. and the authors, these chemical footprints restrict the use of nanomaterials in clinical and biological settings.
Biogenic synthesis—often called "green synthesis"—replaces synthetic reagents with biological machinery. By leveraging the natural chemistry of plants, fungi, and bacteria, researchers can produce stable, functional nanoparticles that are inherently biocompatible and environmentally sustainable.
Phytochemicals as Reducing and Capping Agents
The most common green synthesis route involves aqueous plant extracts. Plants are rich in secondary metabolites like flavonoids, tannins, and polyphenols, which possess high antioxidant activity. In this process, these phytochemicals act as dual-purpose agents: they reduce metal ions (like $Ag^+$ or $Se^{4+}$) into solid nanoparticles and then "cap" the resulting particles to prevent aggregation.
For instance, Juan Shu et al. demonstrated that leaf extracts from Coleus forskohlii could convert metal salts into stable selenium nanoparticles (Se-NPs) capable of mitigating pancreatic damage in rats. Similarly, R. Subashini et al. utilized phytochemicals to valorize agricultural waste, turning spent mushroom substrate into antifungal bio-boards via silver nanoparticle (AgNP) synthesis. This approach is not limited to simple metals; Manisha Bisht et al. showed that fern extracts can effectively replace hazardous chemicals in the production of reduced graphene oxide (rGO).
Microbial and Fungal Bio-factories
Beyond simple extracts, living organisms can serve as biological factories. Bacteria and fungi utilize endogenous cellular processes to reduce metal salts at ambient temperatures, avoiding the high energy consumption of industrial methods.
- Bacterial Synthesis: Maria Sindhura John et al. isolated an Antarctic bacterium, Marinomonas sp. ef1, which produces AgNPs at low temperatures. This process leverages genes acquired through horizontal gene transfer to create particles that are potent against human pathogens but non-toxic to human cells.
- Mycosynthesis: Fungi offer high biomass and easy handling. Ashrit Gulfraz et al. used the fungus Exserohilum rostratum to synthesize AgNPs that act as bioherbicides, damaging weed cells through oxidative stress while leaving rice crops unharmed.
In-Situ Synthesis and Bio-inspired Scaffolds
A more integrated approach treats the final material substrate itself as a chemical reactor. Sunghyun Nam demonstrated this by "growing" AgNPs directly inside raw cotton fibers. By utilizing the inherent sugars and proteins already present in the fiber, the process eliminates the need for external synthetic reducers, resulting in biodegradable, antiviral textiles.
Bio-inspired polymers like polydopamine also serve as effective scaffolds. Wei Wang et al. showed that the amine and hydroxyl groups in polydopamine coatings can reduce gold ions and anchor them to a surface, creating reusable catalysts without hazardous chemicals.
Enhancing Biocompatibility and Functionality
The primary advantage of biogenic synthesis is the resulting "biosafe" profile. Because the nanoparticles are capped with biological molecules rather than toxic surfactants, they integrate more safely with living systems.
- Reduced Cytotoxicity: Across various studies, including work by Xiaomin Yang et al. and Davide Mazzali et al., green-synthesized materials consistently maintain high cell viability (often >80%) even at high concentrations.
- Dual-Functionality in Agriculture: In sustainable farming, biogenic nanoparticles serve a dual role. Usman Shafqat found that plant-derived Zn, Fe, and Cu nanoparticles not only suppress viral diseases in cotton but also act as essential micronutrients, boosting plant growth in a way that traditional pesticides cannot.
- Protein Coronas: The interaction with biological fluids can further enhance efficacy. Huamao Du et al. demonstrated that pre-coating AgNPs with serum proteins (creating a "protein corona") stabilizes the particles in the bloodstream, improving survival rates in septic mice by dampening lethal inflammatory responses.
By shifting from industrial chemistry to bio-inspired reduction, the field moves toward a "circular" nanotechnology where waste products become reagents and the resulting materials are inherently compatible with the environments they are designed to treat.
Key Foundational Work
Construction of Stable Chainlike Au Nanostructures via Silica Coating and Exploration for Potential Photothermal Therapy (2014) — contributed 1 concept elements to this direction.
Cytotoxicity and wound healing properties of PVA/ws-chitosan/glycerol hydrogels made by irradiation followed by freeze–thawing (2010) — contributed 1 concept elements to this direction.